Market Place
Sourcing Support
Pharma & Biotech News #PharmaBuzz
Astra invests US$ 2 bn in US R&D; key AbbVie asset from US$ 8.7 bn Cerevel buy flunks phase 2 trials
Impressions : 461
Astra faces probe in China; AbbVie, EvolveImmune ink potential US$ 1.4 bn deal; EC levies US$ 503 mn fine on Teva
Impressions : 743
AbbVie strengthens Alzheimer's pipeline with US$ 1.4 bn Aliada buyout; Roche expands gene therapy pact with Dyno
Impressions : 667
Sanofi to sell 50% stake in Opella to CD&R, to retain French workforce; AbbVie bags FDA nod for Parkinson's therapy Vyalev
Impressions : 738
Aspiro Pharma's Generics Chlorpromazine HCl Receives Approval in US
18 Nov 2024 //
FDA
Samsung Bioepis's Biologic Epysqli Receives Suppl Approval in US
15 Nov 2024 //
FDA
Celltrion's Biologic Herzuma Receives Suppl Approval in US
14 Nov 2024 //
FDA
Eisai's Biologic Leqembi Receives Suppl Approval in US
14 Nov 2024 //
FDA
Cosette Pharma's Generics Sucralfate Receives Approval in US
13 Nov 2024 //
FDA
Mylan Gmbh's Biologic Ogivri Receives Suppl Approval in US
13 Nov 2024 //
FDA
Macleods's Generics Fenofibrate Receives Approval in US
12 Nov 2024 //
FDA
Apotex's Generics Rivaroxaban HCl Receives Approval in US
07 Nov 2024 //
FDA
Teva Pharma's Generics Fedratinib Receives Tentative Approval in US
07 Nov 2024 //
FDA
Micro Labs's Generics Metolazone Receives Approval in US
06 Nov 2024 //
FDA
Endo Expands Voluntary Recall of Clonazepam Orally Tablets
19 Nov 2024 //
FDA
Frontier Biologics Receives FDA Warning Letter
19 Nov 2024 //
FDA
FDA Issues Untitled Letter to Silliker Inc
18 Nov 2024 //
FDA
FDA Issues Form 483 to Takeda Pharmaceutical
15 Nov 2024 //
FDA
FDA Issues Form 483 to Astellas Pharma
15 Nov 2024 //
FDA
Enforcement Report - Week of November 13, 2024
13 Nov 2024 //
FDA
Zhejiang Qimei Cosmetics Receives FDA Warning Letter
12 Nov 2024 //
FDA
Maxheal Pharmaceuticals Fails EDQM inspection
12 Nov 2024 //
EMA
VitalityVita Issues Voluntary Nationwide Recall of VitalityXtra Capsules
06 Nov 2024 //
FDA
Enforcement Report - Week of November 6, 2024
06 Nov 2024 //
FDA
FDA updates label of 33-year-old cancer drug with dose & warning
21 Nov 2024 //
ENDPTS
Laekna with Lilly to develop muscle preserving obesity drug
21 Nov 2024 //
PRESS RELEASE
Kura Oncology to partner with Kyowa Kirin for blood cancer therapy
21 Nov 2024 //
PR NEWSWIRE
UCB receives FDA approval for BIMZELX For hidradenitis suppurativa
21 Nov 2024 //
PRESS RELEASE
Trump likely to pick Johns Hopkins surgeon, for FDA, sources say
21 Nov 2024 //
REUTERS
Jazz Pharma receive FDA approval for biliary tract cancer treatment
21 Nov 2024 //
REUTERS
Sequana Medical Announces EGM for 20 December 2024
20 Nov 2024 //
GLOBENEWSWIRE
Argenx Advance Efgartigimod SC in Idiopathic Inflammatory Myopathy
20 Nov 2024 //
GLOBENEWSWIRE
Orion and Alligator Bio amend agreement 2 bispecific antibodies
20 Nov 2024 //
PRESS RELEASE
CPHI India reports surge in exhibitor numbers
20 Nov 2024 //
INDPHARMAPOST
Lupin launches Bumetanide Injection USP in US
20 Nov 2024 //
INDPHARMAPOST
BeiGene defends Brukinsa from MSN's generic threat until 2037
19 Nov 2024 //
FIERCE PHARMA
Supreme Court Declines Patent Dispute Over Bausch Diarrhea Drug
18 Nov 2024 //
REUTERS
BMS, Merck, Amgen & more face near-term generic woes: Leerink
13 Nov 2024 //
FIERCE PHARMA
Alembic Pharma Gains USFDA Approval for Ivabradine Tablets
12 Nov 2024 //
EXPRESSPHARMA
Lupin receives tentative FDA approval for Raltegravir tablets
11 Nov 2024 //
EXPRESSPHARMA
Alembic Pharma gets FDA nod for Diltiazem HCl ER capsules
11 Nov 2024 //
BUSINESS STD
Hefty sales of generics boost Teva to another big quarter
07 Nov 2024 //
FIERCE PHARMA
Teva Reports Strong Q3 2024 Results, Raises Financial Outlook
06 Nov 2024 //
GLOBENEWSWIRE
Walgreens agrees to pay $100 mlnt over generic drug pricing
04 Nov 2024 //
REUTERS
Laekna with Lilly to develop muscle preserving obesity drug
21 Nov 2024 //
PRESS RELEASE
Kura Oncology to partner with Kyowa Kirin for blood cancer therapy
21 Nov 2024 //
PR NEWSWIRE
UCB receives FDA approval for BIMZELX For hidradenitis suppurativa
21 Nov 2024 //
PRESS RELEASE
Jazz Pharma receive FDA approval for biliary tract cancer treatment
21 Nov 2024 //
REUTERS
Argenx Advance Efgartigimod SC in Idiopathic Inflammatory Myopathy
20 Nov 2024 //
GLOBENEWSWIRE
Orion and Alligator Bio amend agreement 2 bispecific antibodies
20 Nov 2024 //
PRESS RELEASE
Innate Pharma Releases Its 2025 Financial Calendar
20 Nov 2024 //
BUSINESSWIRE
GSK's itch prospect hits mark in phase 3 liver disease trial
20 Nov 2024 //
FIERCE BIOTECH
Merck says Keytruda injection on par with approved IV version in trial
20 Nov 2024 //
FIERCE PHARMA
WHO lists mpox vaccine by KM Biologics for emergency use
20 Nov 2024 //
REUTERS
Wanbury Q2 FY25 revenue at Rs. 161.2 crore, up 11.6%
16 Nov 2024 //
INDPHARMAPOST
Essential Role of Intellectual Property in Pharmaceutical API Company
15 Nov 2024 //
PRESS RELEASE
FDA request lands Chinese API manufacturer on blocked import list
11 Nov 2024 //
ENDPTS
Evotec Sells API Manufacturing Facility to Monacum Partners
05 Nov 2024 //
ACCESSWIRE
Chongqing Pharma Seeks Public Input On Peptide API Plant Study
04 Nov 2024 //
PRESS RELEASE
Chongqing Xingtaihao Announces For API Line Upgrade Completion
04 Nov 2024 //
PRESS RELEASE
Olon to Host Ultra-Potent Compound Productions in New Facility
04 Nov 2024 //
GLOBENEWSWIRE
Supriya Lifescience reports 19% revenue increase in Q2 FY25
01 Nov 2024 //
INDPHARMAPOST
Fermion - leader in sustainable API manufacturing
29 Oct 2024 //
PRESS RELEASE
Vistin Pharma ASA: Invitation to Q3 2024 conference call
24 Oct 2024 //
GLOBENEWSWIRE
Drugmaker receives FDA warning letter after hindered inspection
20 Nov 2024 //
FDA
FDA Rejects Astellas' Effort to Extend Eye Drug Izervay Use
19 Nov 2024 //
ENPTS
Supreme Court Asks Zydus to Approach Delhi HC Over Sigrima Ban
19 Nov 2024 //
ECONOMICTIMES
VBI recalls hepatitis B shot as it winds down operations
18 Nov 2024 //
FIERCE PHARMA
Endo Expands Voluntary Recall of Clonazepam Due to Mislabeling
18 Nov 2024 //
PR NEWSWIRE
Dr Reddy's, FDC recall products in US for manufacturing issues
17 Nov 2024 //
ECONOMICTIMES
GAO takes FDA to task over lagging drug plant inspections
14 Nov 2024 //
FIERCE PHARMA
FDA slams Merz over 'misleading' Instagram ad for Botox rival
14 Nov 2024 //
FIERCE PHARMA
Supreme Court Rejects Plea to Mandate Doctor on Drug Side-Effects
14 Nov 2024 //
FINANCIALXPRESS
Cipla gets 8 observations after FDA inspection at Bengaluru plant
13 Nov 2024 //
CNBCTV
Emcure Pharma's SAKHI Diabetes Program Makes Asia Book of Records
20 Nov 2024 //
INDPHARMAPOST
Teleflex To Present At 36th Piper Sandler Healthcare Conference
19 Nov 2024 //
GLOBENEWSWIRE
Spineart Celebrates 100,000 Ti-Life Cages Sold Worldwide
19 Nov 2024 //
GLOBENEWSWIRE
Calvient Unveils Practice Intelligence to Revolutionize Healthcare
19 Nov 2024 //
GLOBENEWSWIRE
EDAP Present at AAGL on Focal One HIFU vs Surgery for Endometriosis
19 Nov 2024 //
GLOBENEWSWIRE
Commure Deploys Ambient AI Platform at Tenet Physician Resources
19 Nov 2024 //
GLOBENEWSWIRE
Dror Ortho-Design Introduces ZSmile: Eco-Friendly Orthodontics
19 Nov 2024 //
GLOBENEWSWIRE
Stride Autism Centers Appoints Emily Patrizi As COO
19 Nov 2024 //
GLOBENEWSWIRE
Raleigh Joins Medical Associations to Elevate Skincare Standards
19 Nov 2024 //
GLOBENEWSWIRE
HealthEquity CMO Tia Padia Named "Visionary CMO" at MarCom Awards
19 Nov 2024 //
GLOBENEWSWIRE
Ractigen Wins FDA Orphan Drug Designation for RAG-21 in ALS
19 Nov 2024 //
PR NEWSWIRE
GeneDx Launches GeneDx Discover for Rare Disease Drug Discovery
19 Nov 2024 //
BUSINESSWIRE
Eisai ends lorcaserin development in Dravet syndrome
18 Nov 2024 //
FIERCE PHARMA
Children's Hospital Announces Gene Therapy Results for Danon
18 Nov 2024 //
PR NEWSWIRE
AlveoGene Gets FDA Rare Pediatric Disease Designation for AVG-002
15 Nov 2024 //
GLOBENEWSWIRE
Soligenix Launches Phase 2 Trial for SGX945 in Behçet's Disease
14 Nov 2024 //
PR NEWSWIRE
Biocodex Announces DIACOMIT® Oral Suspension for Dravet Syndrome
14 Nov 2024 //
PR NEWSWIRE
Amgen Presents New Data on Rare Inflammatory Diseases at ACR 2024
14 Nov 2024 //
PR NEWSWIRE
Perspectum Awarded FDA Grant for Rare Disease Biomarker Study
14 Nov 2024 //
BUSINESSWIRE
FDA approves PTC Therapeutics' gene therapy for ultra-rare disorder
14 Nov 2024 //
REUTERS
FDA updates label of 33-year-old cancer drug with dose & warning
21 Nov 2024 //
ENDPTS
Trump likely to pick Johns Hopkins surgeon, for FDA, sources say
21 Nov 2024 //
REUTERS
Sequana Medical Announces EGM for 20 December 2024
20 Nov 2024 //
GLOBENEWSWIRE
CPHI India reports surge in exhibitor numbers
20 Nov 2024 //
INDPHARMAPOST
Trump picks TV's Dr. Oz to run Medicare and Medicaid
20 Nov 2024 //
REUTERS
Pfizer cannot recoup $75 M from SEC insider trading settlement
20 Nov 2024 //
REUTERS
Bayer acquires rights to Cytokinetics' heart drug in Japan
20 Nov 2024 //
REUTERS
CancerVax Lands Top Cancer Expert
19 Nov 2024 //
GLOBENEWSWIRE
Curium Completes Early Enrollment of Phase 3 Prostate Cancer Trial
19 Nov 2024 //
GLOBENEWSWIRE
Augere Medical secures NOK 23M in the "first close" funding round
19 Nov 2024 //
GLOBENEWSWIRE
